| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Albiglutide Does Not Prolong QTc Interval in Healthy Subjects: A Thorough ECG Study
|
Darpo, Borje
|
|
2014
|
5 |
1 |
p. 141-153
|
artikel
|
| 2 |
Carcinogenicity Risk Assessment Supports the Chronic Safety of Dapagliflozin, an Inhibitor of Sodium–Glucose Co-Transporter 2, in the Treatment of Type 2 Diabetes Mellitus
|
Reilly, Timothy P.
|
|
2014
|
5 |
1 |
p. 73-96
|
artikel
|
| 3 |
Choosing Appropriate Glucagon-like Peptide 1 Receptor Agonists: A Patient-Centered Approach
|
Kalra, Sanjay
|
|
2014
|
5 |
1 |
p. 333-340
|
artikel
|
| 4 |
Comparative Effectiveness of Dipeptidylpeptidase-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Mixed Treatment Comparison
|
Craddy, Paul
|
|
2014
|
5 |
1 |
p. 1-41
|
artikel
|
| 5 |
Dapagliflozin Added to Glimepiride in Patients with Type 2 Diabetes Mellitus Sustains Glycemic Control and Weight Loss Over 48 Weeks: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
|
Strojek, Krzysztof
|
|
2014
|
5 |
1 |
p. 267-283
|
artikel
|
| 6 |
Diabetes Education: the Experiences of Young Adults with Type 1 Diabetes
|
Wiley, Janice
|
|
2014
|
5 |
1 |
p. 299-321
|
artikel
|
| 7 |
Distinct Prandial and Basal Glucose-Lowering Effects of Insulin Degludec/Insulin Aspart (IDegAsp) at Steady State in Subjects with Type 1 Diabetes Mellitus
|
Heise, Tim
|
|
2014
|
5 |
1 |
p. 255-265
|
artikel
|
| 8 |
Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus
|
Ascher-Svanum, Haya
|
|
2014
|
5 |
1 |
p. 225-242
|
artikel
|
| 9 |
Effects of Exenatide in a Morbidly Obese Patient with Type 2 Diabetes
|
Kishimoto, Miyako
|
|
2014
|
5 |
1 |
p. 323-332
|
artikel
|
| 10 |
Efficacy and Safety of Vildagliptin as Add-on to Metformin in Japanese Patients with Type 2 Diabetes Mellitus
|
Odawara, Masato
|
|
2014
|
5 |
1 |
p. 169-181
|
artikel
|
| 11 |
Efficacy of Liraglutide in a Real-Life Cohort
|
Heymann, Anthony
|
|
2014
|
5 |
1 |
p. 193-206
|
artikel
|
| 12 |
Erratum to: Efficacy of Liraglutide in a Real-Life Cohort
|
Heymann, Anthony
|
|
2014
|
5 |
1 |
p. 345
|
artikel
|
| 13 |
Insulin Degludec Aspart: The First Co-formulation of Insulin Analogues
|
Kalra, Sanjay
|
|
2014
|
5 |
1 |
p. 65-72
|
artikel
|
| 14 |
Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy
|
Kaku, Kohei
|
|
2014
|
5 |
1 |
p. 97-111
|
artikel
|
| 15 |
Metabolic Effects of Basal or Premixed Insulin Treatment in 5077 Insulin-Naïve Type 2 Diabetes Patients: Registry-Based Observational Study in Clinical Practice
|
Eliasson, Björn
|
|
2014
|
5 |
1 |
p. 243-254
|
artikel
|
| 16 |
Real-Life Effectiveness and Tolerability of Vildagliptin and Other Oral Glucose-Lowering Therapies in Patients with Type 2 Diabetes in Germany
|
Göke, Rüdiger
|
|
2014
|
5 |
1 |
p. 183-191
|
artikel
|
| 17 |
Safety, Tolerability, and Efficacy of Insulin Aspart in People with Type 2 Diabetes, as Biphasic Insulin Aspart or with Basal Insulin: Findings from the Multinational, Non-Interventional A1chieve Study
|
Hajjaji, Issam
|
|
2014
|
5 |
1 |
p. 113-126
|
artikel
|
| 18 |
Self-Reported Frequency and Impact of Hypoglycemic Events in Spain
|
Orozco-Beltrán, Domingo
|
|
2014
|
5 |
1 |
p. 155-168
|
artikel
|
| 19 |
Sitagliptin Improves the Impaired Acute Insulin Response during a Meal Tolerance Test in Japanese Patients with Type 2 Diabetes Mellitus: A Small-Scale Real-World Study
|
Ohkura, Tsuyoshi
|
|
2014
|
5 |
1 |
p. 285-297
|
artikel
|
| 20 |
Testing the Therapeutic Equivalence of Alogliptin, Linagliptin, Saxagliptin, Sitagliptin or Vildagliptin as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes
|
Messori, Andrea
|
|
2014
|
5 |
1 |
p. 341-344
|
artikel
|
| 21 |
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
|
McGill, Janet B.
|
|
2014
|
5 |
1 |
p. 43-63
|
artikel
|
| 22 |
Type 2 Diabetes Mellitus Management and Body Mass Index: Experiences with Initiating Insulin Detemir in the A1chieve Study
|
Khamseh, Mohammed E.
|
|
2014
|
5 |
1 |
p. 127-140
|
artikel
|
| 23 |
Use of Vildagliptin in Management of Type 2 Diabetes: Effectiveness, Treatment Persistence and Safety from the 2-Year Real-Life VILDA Study
|
Simon, Dominique
|
|
2014
|
5 |
1 |
p. 207-224
|
artikel
|
Tijdschrift beschrijving